ArticleNature cancer2023
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Open access · hybridAbstract readPublished Erratum
In one paragraph
Article in Nature cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy.Research (Washington, D.C.) · 2025Article
Corrections and comments
- Erratum for
Authors and funding
30 authors at 9 institutions in 4 countries.
Renáta VáraljaiDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.ORCID http://orcid.org/0000-0001-6852-6859
Lisa ZimmerDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Yahya Al-MataryDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Paulien KapteinDivision of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Lea J AlbrechtDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Batool ShannanDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Jan C BraseNovartis Pharma AG, Basel, Switzerland.
Daniel GusenleitnerNovartis Institutes for BioMedical Research, Inc., Cambridge, MA, USA.
Teresa AmaralDepartment of Dermatology, University Hospital of Tübingen, Tübingen, Germany.
Nina WyssInstitute of Immunobiology, Kantonsspital St. Gallen, Switzerland, Switzerland.
Jochen UtikalSkin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lukas FlatzDepartment of Dermatology, University Hospital of Tübingen, Tübingen, Germany.
Florian RambowDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Hans Christian ReinhardtDepartment of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
Jenny DickDepartment of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-4418-6092
Daniel R EngelDepartment of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany.
Susanne HornDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Selma UgurelDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Wiebke SondermannDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.ORCID http://orcid.org/0000-0002-3684-3523
Elisabeth LivingstoneDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Antje SuckerDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Annette PaschenDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.ORCID http://orcid.org/0000-0003-1651-1262
Fang ZhaoDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.ORCID http://orcid.org/0000-0002-2746-9242
Jan M PlackeDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Jasmin M KloseDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Wolfgang P FendlerDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Daniela S ThommenDivision of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-7431-2854
Iris HelfrichDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Dirk SchadendorfDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.ORCID http://orcid.org/0000-0003-3524-7858
Alexander RoeschDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. alexander.roesch@uk-essen.de.ORCID http://orcid.org/0000-0002-0773-6067
Deutschen Konsortium für Translationale Krebsforschung · DEEssen University Hospital · DEKantonsspital St. Gallen · CHThe Netherlands Cancer Institute · NLUniversity of Duisburg-Essen · DENovartis (Switzerland) · CHNovartis (United States) · USUniversity Children's Hospital Tübingen · DEUniversity of Mannheim · DE
Funding
Deutsche Forschungsgemeinschaft (German Research Foundation) 424228829 (SFB 1430)Deutsche Forschungsgemeinschaft (German Research Foundation) HE 5294/2-1 (KFO 337)Deutsche Forschungsgemeinschaft (German Research Foundation) HO 6389/2-1 (KFO 337)Deutsche Forschungsgemeinschaft (German Research Foundation) PA 2376/1-1 (KFO 337)Deutsche Forschungsgemeinschaft (German Research Foundation) RO 3577/7-1 (KFO 337)Deutsche Forschungsgemeinschaft (German Research Foundation) SCHA 422/17-1 (KFO 337)
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.